Objective: To compare the pharmacokinetic profile and bioavailability of budesonide after inhalation from the Clickhaler® dry powder inhaler with the Turbuhaler® as standard. Design: Randomised ...

Cumulative propellant loss as a function of study duration for Proventil HFA and Ventolin HFA metered-dose inhalers. Albuterol dose per actuation as a function of temperature for Proventil HFA ...

Asthma can cause excess mucus buildup in the lungs, leading to chest congestion. It usually worsens when you have a respiratory infection or when your allergies are acting up. However, you can also ...

The inhaler options have broadened in recent years, with products on the market that include everything from the short-acting Proventil (albuterol) rescue inhaler to next-generation ... This group ...

Just a couple of years ago, herbal inhalers were seen as something only aunties and uncles use. You can almost picture a caricature of them taking comically deep whiffs to clear their nasal packages, ...

The dosage can vary depending on what condition the drug is used for. Albuterol inhaler is approved by the Food and Drug Administration (FDA) for the following uses: Albuterol belongs to a class ...

1. In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was not associated with improved clinical outcomes compared to receiving ...

In the present cohort study, the researchers compared the effectiveness and safety of two single-inhaler triple therapies for COPD — budesonide-glycopyrrolate-formoterol (administered twice ...

and colleagues compared the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a twice-daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once-daily dry powder ...

30 in The BMJ. William B. Feldman, M.D., M.P.H., from Brigham and Women's Hospital in Boston, and colleagues compared the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a ...

30 in The BMJ. William B. Feldman, MD, MPH, from Brigham and Women’s Hospital in Boston, and colleagues compared the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a twice-daily ...